Profile and Antithrombotic Management of Patients With NVAF Attending Internal Medicine Departments in Spain (PERFILAR Study)

Completed

Phase N/A Results N/A

Update History

19 May '17
The gender criteria for eligibility was updated to "All."
12 Feb '16
A location was updated in Barcelona.
New
The overall status was removed for Local Institution.
2 Oct '15
The eligibility criteria were updated.
New
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: - Adult patients (≥18 years old) - Patients diagnosed with Non-valvular atrial fibrillation (NVAF) any time prior to the inclusion date (prevalent or incident patients) - Patients treated or not treated with an antithrombotic therapy - Treated patients should have begun treatment prior to the inclusion visit - Patients attending Internal Medicine departments, either for a hospital appointment (outpatients) or hospitalization (inpatients) for any reason) - Patients which signed the informed consent Exclusion Criteria: - Patients diagnosed with valvular atrial fibrillation any time in their medical records - Patients with anticoagulant treatment prescribed for venous thromboembolic disease any time prior to the inclusion date - Patients which participated in any clinical trial with anticoagulant and/or antiplatelet agents in the previous six months - Patients incapable of giving their informed consent
Old
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: - Adult patients (≥18 years old) - Patients diagnosed with Non-valvular atrial fibrillation (NVAF) any time prior to the inclusion date (prevalent or incident patients) - Patients treated or not treated with an antithrombotic therapy - Treated patients should have begun treatment prior to the inclusion visit - Patients attending Internal Medicine departments, either for a hospital appointment (outpatients) or hospitalization (inpatients) for any reason) - Patients which signed the informed consent Exclusion Criteria: - Patients diagnosed with valvular atrial fibrillation any time in their medical records - Patients with anticoagulant treatment prescribed for venous thromboembolic disease any time prior to the inclusion date - Patients which participated in any clinical trial with anticoagulant and/or antiplatelet agents in the previous six months - Patients incapable of giving their informed consent